TLS IS THE MOST COMMON DISEASE-RELATED EMERGENCY IN HEMATOLOGIC CANCERS1
37% of patients with hematologic malignancies developed TLS per year from 2010 to 20142
- This is based on data from the National Inpatient Sample Database, the largest publicly available all-payer inpatient database
- A total of 15,051 cases of TLS were identified among the 40,494 patients with hematologic malignancies during this period
Incidence of TLS in patients with hematologic malignancies2
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) recommend to best manage TLS, anticipate it and initiate treatment prior to anticancer therapy for patients with CLL/SLL, B-cell lymphoma, and ALL3,4
CLL/SLL=chronic lymphocytic leukemia/small lymphocytic lymphoma; ALL=acute lymphoblastic leukemia.